How Plasma Therapeutics leverage IT to transform Drug Discovery

It was started as an entrepreneurial venture by a team of young scientists from one of the world's largest pharmaceutical companies.

.

The global headquarters of PTI was located in the United States and the research centers were located in United States, France and India. The objective of the company was to identify new drug targets as well as discover new candidate drugs.

.

The board of PTI wanted to leverage IT innovatively to drive efficiency and productivity thereby achieving more with fewer resources. Using the hypothetical PTI as an example, the article illustrates how life sciences companies can leverage IT to improve productivity and profits.

.

A related approach to this is as follows:-

Implementing Compliant Pharmaceutical and Biotechnology Processes Using Oracle's E-Business Suite: A White Paper Discussing the Compliant Use of the Oracle E-Records Framework in the Pharmaceutical and Biotechnology Sectors.

.

A number of suppliers to the Life Sciences sector claim to have developed applications or solutions that are 'compliant' to 21CFR Part 11.

Many of these are in fact only partial solutions, do not address fundamental issues of data integrity or do not provide the necessary flexibility to allow for a case-by-case interpretation of the predicate rules.

 .

 Oracle Corporation, supported by Mi Services, have developed a flexible and compliant framework that meets the technical requirements of these processes but also allows end user organizations to ensure that their business processes can follow industry best practice in a manner that is compliant with US, EU and other international pharmaceutical and biotechnology regulations.